>북미 제약용 실리카겔 시장, 유형(액체 및 고체), 겔 브레드 유형(흰색 실리카겔 브레드, 주황색 실리카겔 브레드 및 파란색 실리카겔 브레드), 형태( 착색제 , 윤활제 및 활택제, 결합제, 붕괴제, 향미제, 캡슐, 용매, 코팅제 , 방부제, 필러 및 희석제, 현탁액, 점도제 및 기타), 포장 유형(캐니스터, 파우치, 사쉐, 패킷, 용기, 병 및 기타), 크로마토그래피(분석 크로마토그래피, 제조 크로마토그래피, 공정 크로마토그래피 및 중력 크로마토그래피) 산업 동향 및 2029년까지의 예측.
시장 분석 및 통찰력
북미 제약용 실리카겔 시장은 2022년부터 2029년까지의 예측 기간 동안 상당한 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2022년부터 2029년까지의 예측 기간 동안 3.2%의 CAGR로 성장하고 있으며 2029년까지 50,289.86천 달러에 도달할 것으로 분석합니다.
제약용 실리카겔 시장 성장을 견인하는 주요 요인은 의약품에 대한 수요 증가, 제약 부문의 광범위한 연구개발, 분자 성분을 검출하기 위한 크로마토그래피를 사용하는 생명공학에 대한 지출 증가입니다.
정지상으로서의 실리카겔은 컬럼 크로마토그래피와 다른 분리 기술에서 사용되는 최고의 흡착제 중 하나로 널리 받아들여지고 있습니다. 주요 장점 중 하나는 흡착에 대한 엄청난 친화력입니다. 또한, 여러 가지 크기와 유형으로 상업적으로 매우 쉽게 구할 수 있습니다. 컬럼 크로마토그래피에서 정지상으로 실리카겔을 사용하는 주요한 이유는 특정 방법에 필요한 입자 크기의 추출물을 얻는 것이 가능하다는 것입니다.
실리카겔은 약산성이며 염기성 물질을 흡착하는 능력이 강한 극성 흡착제입니다. 실리카겔은 역상 분배 크로마토그래피에서 가장 널리 사용되며 스테로이드, 아미노산, 지질, 알칼로이드 및 여러 제약 공정의 분리로 구성된 광범위한 응용 분야가 있습니다.
북미 제약 등급 실리카겔 시장 보고서는 시장 점유율, 새로운 개발, 국내 및 지역 시장 참여자의 영향에 대한 세부 정보를 제공하고, 새로운 수익 주머니, 시장 규정의 변화, 제품 승인, 전략적 의사 결정, 제품 출시, 지리적 확장 및 시장의 기술 혁신 측면에서 기회를 분석합니다. 분석 및 시장 시나리오를 이해하려면 분석가 브리핑을 위해 저희에게 연락하세요. 저희 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드릴 것입니다.
|
보고서 메트릭 |
세부 |
|
예측 기간 |
2022년부터 2029년까지 |
|
기준 연도 |
2021 |
|
역사적 연도 |
2020 (2019-2014까지 사용자 정의 가능) |
|
양적 단위 |
매출은 천 달러, 양은 킬로톤, 가격은 달러로 표시 |
|
다루는 세그먼트 |
By Type (Liquid And Solid), Gel Breads Type (White Silica Gel Breads, Orange Silica Gel Breads, and Blue Silica Gel Breads), Form (Colorants, Lubricants & Glidants, Binders, Disintegrants, Flavoring Agents, Capsules, Solvents, Coatings, Preservatives, Fillers & Diluents, Suspension, Viscosity Agents And Others), Packaging Type (Canisters, Pouches, Sachets, Packets, Containers, Bottles, and Others), Chromatography (Analytical Chromatography, Preparative Chromatography, Process Chromatography, and Gravity Chromatography) |
|
Countries Covered |
U.S., Canada, and Mexico |
|
Market Players Covered |
BASF SE, DuPont, Solvay, Merck KGAA, W. R. Grace & Co.-Conn, Evonik Industries AG, Multisorb Technologies, Clariant AG, Fuji Silysia Chemical |
Pharmaceutical Grade Silica Gel Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
Drivers
- Growing Demand for Medicinal Drugs
The growing pharmaceutical industry has propelled the growth of drug production, which has increased the consumption of silica gel over the years. The demand for silica gel is expected to increase further as chromatography can be performed using silica gel. Silica gel column chromatography is widely used in the pharmaceutical industry to collect or separate different drug components.
- Extensive Deployment of R&D in the Pharma Sector
The growing need for data integrity and automation has led to the integration of sophisticated software with contemporary chromatography systems. These advances in technology for the development of improved systems, innovative and disposable columns, better-performing resins, and other accessories may help the market to grow significantly.
- Rising Spending on Biotechnology using Chromatography for Detecting Molecular Components
Bioencapsulation involves the envelopment of tissues or biologically active substances in a semipermeable membrane to protect the enclosed biological structures such as cells, enzymes, drugs, and magnetic materials among others. The continuous research and development of silica gel based techniques like chromatography from the biotech end will lead to the growth of the North America pharmaceutical grade silica gel market.
Opportunities
- Lucrative Outlook Towards In-House R&D
Chromatography is a continuously evolving technique and an increase in the demand for chromatography instruments and reagents for research and development is a major factor driving the growth and demand for the North America pharmaceutical grade silica gel market.
- Easy Availability of Raw Materials through Well-Established Strategic Partners
The amorphous form of silicon dioxide is used to manufacture pharmaceutical-based silica gel. The enormous availability of different raw materials on the earth’s surface as well the ability to synthetically produce these raw materials along with the companies’ producing pharmaceutical grade silica gel well-established partnerships with various suppliers and partners, which continuously supply high-grade raw materials to these players for the production of silica gel.
Restraints/Challenges
- Stringent Regulations by the Government
USP's drug standards are enforceable in the U.S. by the Food and Drug Administration (FDA) and are also used in more than 140 countries across the globe. In the Pharmacy Act 1948 of India, there are various stringent regulations regarding the composition of drugs, which requires the pharmacists/chemists to follow various procedures and screening to get approved by the government. These stringent rules and regulations might be one of the biggest restraints faced by the North America pharmaceutical-grade silica gel market.
- The Availability of Substitutes
Free silanols on the surface of silica are responsible for detrimental interactions of those compounds and the stationary phase. These show bad peak shape and low efficiency. This has also inclined manufacturers to opt for substitutes present in the market. For these reasons, several new stationary phases such as non-silica stationary phases, which have reduced and/or shielded silanols, are being introduced into the market.
- Pharmaceutical Items Meet Stringent Quality Control and Performance Standards
Across the globe, every government allocates a substantial proportion of its total health budget to medicines and pharmaceutical items. In developing countries, considerable administrative and technical efforts are directed to ensure that the patients and consumers receive effective medicines of good quality without any compromise on the quality.
- Limited Application Scope to Non-Volatile Compounds
The temperature of the system using silica gel for volatile compounds needs to be maintained at lower levels so that the compound does not vaporize very fast and there is a total loss of the sample before it is utilized and separated by the silica gel plate. Therefore, the scope of silica gel’s application is limited to non-volatile compounds, which may challenge the growth of the North America pharmaceutical grade silica gel market.
Recent Development
- In February 2022, DuPont launched a new online sales portal for the needs of bioprocessing industry purchasers. DuPont bioprocessing enables sophisticated separations and purification for therapeutics, with different DuPont brands such as AmberChrom and AmberLite being very well established in the biopharma industry.
North America Pharmaceutical Grade Silica Gel Market Scope
North America pharmaceutical grade silica gel market is categorized based on type, gel breads type, form, packaging type, and chromatography. The growth amongst these segments will help you analyze major growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.
Type
- Solid
- Liquid
On the basis of type, the North America pharmaceutical grade silica gel market is segmented into solid and liquid.
Gel Breads Type
- White Silica Gel Breads
- Orange Silica Gel Breads
- Blue Silica Gel Breads
On the basis of gel breads type, the North America pharmaceutical grade silica gel market is segmented into white silica gel breads, orange silica gel breads, and blue silica gel breads.
Form
- Fillers & Diluents
- Binders
- Disintegrants
- Lubricants & Glidants
- Colorants
- Flavoring Agents
- Preservatives
- Solvents
- Capsules
- Viscosity Agents
- Suspension
- Coatings
On the basis of form, the North America pharmaceutical grade silica gel market is segmented into colorants, lubricants & glidants, binders, disintegrants, flavoring agents, capsules, solvents, coatings, preservatives, fillers & diluents, suspension, viscosity agents, and others hospitals and clinics, diagnostic centers, academic institutes and others.
Packaging Type
- Pouches
- Sachets
- Packets
- Cannisters
- Containers
- Bottles
- Others
On the basis of packaging type, the North America pharmaceutical grade silica gel market is segmented into canisters, pouches, sachets, packets, containers, bottles, and others.
Chromatography
- Analytical Chromatography
- Preparative Chromatography
- Process Chromatography
On the basis of chromatography, the North America pharmaceutical grade silica gel market is segmented into analytical chromatography, preparative chromatography, process chromatography, and gravity chromatography.
Pharmaceutical Grade Silica Gel Market Regional Analysis/Insights
The pharmaceutical-grade silica gel market is analysed and market size insights and trends are provided by country, type, gel breads type, form, packaging type, and chromatography as referenced above.
North America pharmaceutical-grade silica gel market is further segmented into major countries including the U.S., Canada and Mexico.
The U.S. in North America dominates the pharmaceutical-grade silica gel market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major key players and well-developed healthcare infrastructure in the country.
보고서의 국가 섹션은 또한 현재 및 미래 시장 추세에 영향을 미치는 개별 시장 영향 요인과 시장 규정의 변화를 제공합니다. 신규 및 교체 판매, 국가 인구 통계, 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 북미 브랜드의 존재 및 가용성과 국내 및 국내 브랜드와의 치열한 경쟁으로 인해 직면한 과제, 판매 채널의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.
경쟁 환경 및 북미 제약 등급 실리카겔 시장 점유율 분석
북미 제약 등급 실리카겔 시장 경쟁 구도는 경쟁자에 대한 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 제품 시험 파이프라인, 제품 승인, 특허, 제품 폭과 폭, 응용 분야 우세, 기술 수명선 곡선입니다. 위에 제공된 데이터 포인트는 제약 등급 실리카겔 시장과 관련된 회사의 초점에만 관련이 있습니다.
북미 제약용 실리카겔 시장의 주요 참여 기업으로는 BASF SE, DuPont, Solvay, Merck KGAA, WR Grace & Co.-Conn, Evonik Industries AG, Multisorb Technologies, Clariant AG, Fuji Silysia Chemical 등이 있습니다.
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석 및 추정됩니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 기본(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 이 외에도 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 회사 시장 점유율 분석, 측정 표준, 북미 대 지역 및 공급업체 점유율 분석이 포함됩니다. 추가 문의 사항이 있는 경우 분석가 전화를 요청하십시오.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET
1.4 LIMITATION
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 TYPE LIFE LINE CURVE
2.7 MULTIVARIATE MODELING
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 DBMR MARKET CHALLENGE MATRIX
2.11 DBMR VENDOR SHARE ANALYSIS
2.12 IMPORT-EXPORT DATA
2.13 SECONDARY SOURCES
2.14 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTLE ANALYSIS
4.1.1 POLITICAL FACTORS
4.1.2 ECONOMIC FACTORS
4.1.3 SOCIAL FACTORS
4.1.4 TECHNOLOGICAL FACTORS
4.1.5 LEGAL FACTORS
4.1.6 ENVIRONMENTAL FACTORS
4.2 PORTER’S FIVE FORCES:
4.2.1 THREAT OF NEW ENTRANTS
4.2.2 THREAT OF SUBSTITUTES
4.2.3 CUSTOMER BARGAINING POWER
4.2.4 SUPPLIER BARGAINING POWER
4.2.5 INTERNAL COMPETITION (RIVALRY)
4.3 CLIMATE CHANGE SCENARIO
4.4 RAW MATERIAL PRODUCTION COVERAGE
4.5 TECHNOLOGY ADVANCEMENTS
4.6 REGULATORY COVERAGE
4.7 SUPPLY CHAIN ANALYSIS
4.7.1 OVERVIEW
4.7.2 RAW MATERIAL PROCUREMENT
4.7.2.1 MANUFACTURING AND PACKING
4.7.2.2 MARKETING AND DISTRIBUTION
4.7.2.3 END USERS
4.7.3 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS
4.8 VENDOR SELECTION CRITERIA
5 REGIONAL SUMMARY
5.1 NORTH AMERICA
5.2 ASIA-PACIFIC
5.3 EUROPE
5.4 NORTH AMERICA
5.5 MIDDLE EAST AND AFRICA
5.6 SOUTH AMERICA
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 GROWING DEMAND FOR MEDICINAL DRUGS
6.1.2 EXTENSIVE DEPLOYMENT OF R&D IN THE PHARMA SECTOR
6.1.3 RISING EXPENSES ON BIOTECHNOLOGY USING CHROMATOGRAPHY FOR DETECTING MOLECULAR COMPONENTS
6.2 RESTRAINTS
6.2.1 STRINGENT REGULATIONS BY THE GOVERNMENT
6.2.2 AVAILABILITY OF SUBSTITUTES
6.2.3 RESTRICTIONS ON DERMAL AND ORAL EXPOSURE TO PHARMACEUTICAL GRADE SILICA GEL
6.2.4 HIGH PRICE OF SILICA GEL
6.3 OPPORTUNITIES
6.3.1 LUCRATIVE OUTLOOK TOWARDS IN-HOUSE R&D
6.3.2 EASY AVAILABILITY OF RAW MATERIALS THROUGH WELL-ESTABLISHED STRATEGIC PARTNERS
6.4 CHALLENGES
6.4.1 PHARMACEUTICAL ITEMS MEET STRINGENT QUALITY CONTROL AND PERFORMANCE STANDARDS
6.4.2 LIMITED APPLICATION SCOPE TO NON-VOLATILE COMPOUNDS
7 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE
7.1 OVERVIEW
7.2 SOLID
7.3 LIQUID
8 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY GEL BEADS TYPE
8.1 OVERVIEW
8.2 WHITE SILICA GEL BEADS
8.3 ORANGE SILICA GEL BEADS
8.4 BLUE SILICA GEL BEADS
9 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY FORM
9.1 OVERVIEW
9.2 FILLERS & DILUENTS
9.3 BINDERS
9.4 DISINTEGRANTS
9.5 LUBRICANTS & GLIDANTS
9.6 COLORANTS
9.7 FLAVORING AGENTS
9.8 PRESERVATIVES
9.9 SOLVENTS
9.1 CAPSULES
9.11 VISCOSITY AGENTS
9.12 SUSPENSION
9.13 COATINGS
10 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY PACKAGING TYPE
10.1 OVERVIEW
10.2 POUCHES
10.3 SACHETS
10.4 PACKETS
10.5 CANISTERS
10.6 CONTAINERS
10.7 BOTTLES
10.8 OTHERS
11 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY CHROMATOGRAPHY
11.1 OVERVIEW
11.2 ANALYTICAL CHROMATOGRAPHY
11.3 PREPARATIVE CHROMATOGRAPHY
11.4 PROCESS CHROMATOGRAPHY
11.5 GRAVITY CHROMATOGRAPHY
12 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION
12.1 NORTH AMERICA
12.1.1 U.S.
12.1.2 CANADA
12.1.3 MEXICO
13 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
13.1.1 COLLABORATIONS
13.1.2 EXPANSIONS
13.1.3 NEW PRODUCT DEVELOPMENTS
14 SWOT ANALYSIS
15 COMPANY PROFILES
15.1 BASF SE
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT UPDATE
15.2 DUPONT
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT UPDATES
15.3 SOLVAY
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT UPDATES
15.4 MERCK KGAA
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT UPDATE
15.5 W. R. GRACE & CO.-CONN
15.5.1 COMPANY SNAPSHOT
15.5.2 COMPANY SHARE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT UPDATE
15.6 EVONIK INDUSTRIES AG
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT UPDATES
15.7 CLARIANT
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT UPDATES
15.8 DESICCARE, INC
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT UPDATE
15.9 FUJI SILYSIA CHEMICAL LTD
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT UPDATE
15.1 INTERRA NORTH AMERICA
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT UPDATE
15.11 MULTISORB
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT UPDATE
16 QUESTIONNAIRE
17 RELATED REPORTS
표 목록
TABLE 1 IMPORT DATA OF SILICON DIOXIDE; HS CODE - PRODUCT: 281122 (USD THOUSAND)
TABLE 2 EXPORT DATA OF SILICON DIOXIDE; HS CODE - PRODUCT: 281122 (USD THOUSAND)
TABLE 3 REGULATORY FRAMEWORK
TABLE 4 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 5 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (KILO TONS)
TABLE 6 NORTH AMERICA SOLID IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 7 NORTH AMERICA SOLID IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (KILO TONS)
TABLE 8 NORTH AMERICA LIQUID IN NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 9 NORTH AMERICA LIQUID IN NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (KILO TONS)
TABLE 10 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY GEL BEADS TYPE, 2020-2029 (USD THOUSAND)
TABLE 11 NORTH AMERICA WHITE SILICA GEL BEADS IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 12 NORTH AMERICA ORANGE SILICA GEL BEADS IN NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 13 NORTH AMERICA BLUE SILICA GEL BEADS IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 14 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY FORM, 2020-2029 (USD THOUSAND)
TABLE 15 NORTH AMERICA FILLERS & DILUENTS IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 16 NORTH AMERICA BINDERS IN NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 17 NORTH AMERICA DISINTEGRANTS IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 18 NORTH AMERICA LUBRICANTS & GLIDANTS IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 19 NORTH AMERICA COLORANTS IN NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 20 NORTH AMERICA FLAVORING AGENTS IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 21 NORTH AMERICA PRESERVATIVES IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 22 NORTH AMERICA SOLVENTS IN NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 23 NORTH AMERICA CAPSULES IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 24 NORTH AMERICA VISCOSITY AGENTS IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 25 NORTH AMERICA SUSPENSION IN NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 26 NORTH AMERICA COATINGS IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 27 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY PACKAGING TYPE, 2020-2029 (USD THOUSAND)
TABLE 28 NORTH AMERICA POUCHES IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 29 NORTH AMERICA SACHETS IN NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 30 NORTH AMERICA PACKETS IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 31 NORTH AMERICA CANISTERS IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 32 NORTH AMERICA CONTAINERS IN NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 33 NORTH AMERICA BOTTLES IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 34 NORTH AMERICA OTHERS IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 35 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY CHROMATOGRAPHY, 2020-2029 (USD THOUSAND)
TABLE 36 NORTH AMERICA ANALYTICAL CHROMATOGRAPHY IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 37 NORTH AMERICA PREPARATIVE CHROMATOGRAPHY IN NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 38 NORTH AMERICA PROCESS CHROMATOGRAPHY IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 39 NORTH AMERICA GRAVITY CHROMATOGRAPHY IN PHARMACEUTICAL GRADE SILICA GEL MARKET, BY REGION, 2020-2029 (USD THOUSAND)
TABLE 40 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY COUNTRY, 2020-2029 (USD THOUSAND)
TABLE 41 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY COUNTRY, 2020-2029 (KILO TONS)
TABLE 42 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 43 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (KILO TONS)
TABLE 44 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY GEL BEADS TYPE, 2020-2029 (USD THOUSAND)
TABLE 45 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY FORM, 2020-2029 (USD THOUSAND)
TABLE 46 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY PACKAGING TYPE, 2020-2029 (USD THOUSAND)
TABLE 47 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY CHROMATOGRAPHY, 2020-2029 (USD THOUSAND)
TABLE 48 U.S. PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 49 U.S. PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (KILO TONS)
TABLE 50 U.S. PHARMACEUTICAL GRADE SILICA GEL MARKET, BY GEL BEADS TYPE, 2020-2029 (USD THOUSAND)
TABLE 51 U.S. PHARMACEUTICAL GRADE SILICA GEL MARKET, BY FORM, 2020-2029 (USD THOUSAND)
TABLE 52 U.S. PHARMACEUTICAL GRADE SILICA GEL MARKET, BY PACKAGING TYPE, 2020-2029 (USD THOUSAND)
TABLE 53 U.S. PHARMACEUTICAL GRADE SILICA GEL MARKET, BY CHROMATOGRAPHY, 2020-2029 (USD THOUSAND)
TABLE 54 CANADA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 55 CANADA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (KILO TONS)
TABLE 56 CANADA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY GEL BEADS TYPE, 2020-2029 (USD THOUSAND)
TABLE 57 CANADA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY FORM, 2020-2029 (USD THOUSAND)
TABLE 58 CANADA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY PACKAGING TYPE, 2020-2029 (USD THOUSAND)
TABLE 59 CANADA PHARMACEUTICAL GRADE SILICA GEL MARKET, BY CHROMATOGRAPHY, 2020-2029 (USD THOUSAND)
TABLE 60 MEXICO PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (USD THOUSAND)
TABLE 61 MEXICO PHARMACEUTICAL GRADE SILICA GEL MARKET, BY TYPE, 2020-2029 (KILO TONS)
TABLE 62 MEXICO PHARMACEUTICAL GRADE SILICA GEL MARKET, BY GEL BEADS TYPE, 2020-2029 (USD THOUSAND)
TABLE 63 MEXICO PHARMACEUTICAL GRADE SILICA GEL MARKET, BY FORM, 2020-2029 (USD THOUSAND)
TABLE 64 MEXICO PHARMACEUTICAL GRADE SILICA GEL MARKET, BY PACKAGING TYPE, 2020-2029 (USD THOUSAND)
TABLE 65 MEXICO PHARMACEUTICAL GRADE SILICA GEL MARKET, BY CHROMATOGRAPHY, 2020-2029 (USD THOUSAND)
그림 목록
FIGURE 1 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET: TYPE LIFE LINE CURVE
FIGURE 7 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET: MULTIVARIATE MODELLING
FIGURE 8 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 9 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET: DBMR MARKET POSITION GRID
FIGURE 10 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET: CHALLENGE MATRIX
FIGURE 11 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET: VENDOR SHARE ANALYSIS
FIGURE 12 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET: SEGMENTATION
FIGURE 13 ASIA-PACIFIC IS EXPECTED TO DOMINATE NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET AND IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD
FIGURE 14 GROWING DEMAND FOR MEDICINAL DRUGS IS EXPECTED TO DRIVE NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET IN THE FORECAST PERIOD
FIGURE 15 SOLID SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET IN 2022 & 2029
FIGURE 16 SUPPLY CHAIN ANALYSIS- NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET
FIGURE 17 VENDOR SELECTION CRITERIA
FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET
FIGURE 19 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET: BY TYPE, 2021
FIGURE 20 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET: BY GEL BEADS TYPE, 2021
FIGURE 21 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET: BY FORM, 2021
FIGURE 22 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET: BY PACKAGING TYPE, 2021
FIGURE 23 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET: BY CHROMATOGRAPHY, 2021
FIGURE 24 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET: SNAPSHOT (2021)
FIGURE 25 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET: BY COUNTRY (2021)
FIGURE 26 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET: BY COUNTRY (2022 & 2029)
FIGURE 27 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET: BY COUNTRY (2021 & 2029)
FIGURE 28 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET: BY TYPE (2022-2029)
FIGURE 29 NORTH AMERICA PHARMACEUTICAL GRADE SILICA GEL MARKET: company share 2021 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
